Blinding: Who, what, when, why, how?

Canadian Journal of Surgery

Volumn 53, Issue 5, 2010, Pages 345-348

  Karanicolas, Paul J ^a,e   Farrokhyar, Forough ^b,c   Bhandari, Mohit ^b,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Departments of Clinical Epidemiology and Biostatistics   (Canada)

^c Departments of Surgery   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOUBLE BLIND PROCEDURE; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE; SURGERY;

DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; SURGICAL PROCEDURES, OPERATIVE;

EID: 77958196231     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Doing more good than harm: The evaluation of health care interventions. Conference proceedings. New York (NY): 1993 Mar. 22-25. Ann N Y Acad Sci 1993;703:1-341.
2. Sackett DL. Bias in analytic research. J Chronic Dis 1979;32:51-63.
3. Altman DG, Schulz KF. Statistics notes: Concealing treatment allocation in randomised trials. BMJ 2001;323:446-447
4. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical eviDence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
5. Balk EM, Bonis PA, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. JAMA 2002;287:2973-2982
6. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46
7. Schulz KF, Grimes DA. Blinding in randomised trials: Hiding who got what. Lancet 2002;359:696-700.
8. Noseworthy JH, Ebers GC, VanDervoort MK, et al. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994;44:16-20.
9. Devereaux PJ, Manns BJ, Ghali WA, et al. Physician interpretations and textbook Definitions of blinding terminology in randomized controlled trials. JAMA 2001;285:2000-2003
10. Kao LS, Aaron BC, Dellinger EP. Trials and tribulations. Current challenges in conducting clinical trials. Arch Surg 2003;138:59-62.
11. Lilford R, Braunholtz D, Harris J, et al. Trials in surgery. Br J Surg 2004;91:6-16.
12. McCulloch P, Taylor I, Sasako M, et al. Randomised trials in surgery: Problems and possible solutions. BMJ 2002;324:1448-1451
13. Yang H, Watson D, Lally C, et al. Randomized trial of division versus nondivision of the short gastric vessels during laparoscopic Nissen fundoplication: 10-year outcomes. Ann Surg 2008;247:38-42.
14. Powell JT, Brown LC, Forbes JF, et al. Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg 2007;94:702-708
15. Macklin R. The ethical problems with sham surgery in clinical research. N Engl J Med 1999;341:992-996
16. Karanicolas PJ, Bhandari M, Taromi B, et al. Blinding of outcomes in trials of orthopaedic trauma: An opportunity to enhance the validity of clinical trials. J Bone Joint Surg Am 2008;90:1026-1033
17. Sackett DL. Measuring the success of blinding in RCTs: Don't, must, can't or needn't? Int J EpiDemiol 2007;36:664-665
18. Karanicolas PJ, Bhandari M, Walter SD, et al. Radiographs of hip fractures were digitally altered to mask surgeons to the type of implant without compromising the reliability of quality ratings or making the rating process more difficult. J Clin EpiDemiol 2009;62: 214-223
19. Devereaux PJ, Bhandari M, Clarke M, et al. Need for expertise based randomised controlled trials. BMJ 2005;330:88.